The research and development (R&D) tax credit is one of the most significant domestic tax credits remaining under current tax law. Coupled with immediate expensing for domestic research and experimental (R&E) expenditures, savvy corporate tax teams can use these important tools to implement federal tax planning strategies that maximize their company’s cash flow.
But the tax issues around R&D investment and acquisitions are complex and, like many other aspects of corporate tax planning, require forethought and a deep understanding of recent changes. Tax professionals must stay up to date on developments to guide the right tax-optimized decisions, both now and in the future.
Read on to gain timely and valuable insight into the R&D tax credit, including eligibility and limitations, as well as insight into the deductibility of R&E expenditures.
[Download the full R&D Special Report to see detailed analysis of Sections 41, 174, and 174A.]
Are research and development expenses tax deductible?
Congress created three important incentives for a business to invest in research activities in the United States:
- The ability to immediately deduct domestic R&E expenses in the tax year incurred. (I.R.C. §174A)
- The ability to capitalize and amortize foreign R&E expenses over 15 years. (I.R.C. §174)
- The ability to claim an immediate credit for qualified research expenses. (I.R.C. §41)
Eligible research costs include those paid or incurred for research conducted by the taxpayer, as well as research conducted on the taxpayer’s behalf.
What Section 174 means for deducting R&E costs
On July 4, 2025, the One Big Beautiful Bill Act (OBBBA) reinstated, and made permanent, immediate expensing for domestic R&E expenditures. Section 174A allows a deduction for any domestic R&E expenditures paid or incurred by the taxpayer during the taxable year.
It is significant that pre-OBBBA rules requiring capitalization and amortization of domestic R&E expenditures still apply for taxable years beginning in 2022 through 2024, but Congress provided two transition rules. First, taxpayers can deduct any remaining unamortized domestic R&E costs entirely in 2025, or over a 2-year period (2025 and 2026). Second, taxpayers that are “eligible small businesses” in 2025 may instead elect to apply §174A retroactively by amending their 2022-2024 taxable returns to deduct R&E costs immediately.
Amortization of foreign R&E expenses
For taxable years beginning on or after January 1, 2022, §174 requires that foreign R&E expenditures be capitalized and amortized ratably over a 15-year period. Contrast with the immediate deduction available for domestic R&E expenditures, the post-OBBBA rules incentivize onshore research.
Qualifying R&E expenses
The purpose behind §174 and §174A is to incentivize investment in R&D and breakthrough technologies by eliminating uncertainty concerning the tax treatment of such expenditures. Research and experimentation are basic activities that must precede the development and application to production of new techniques and equipment, as well as the development and manufacture of new products.
Qualifying expenses are a broad category, and include items like patent fees, salaries, drawing and models, and even attorney’s fees.
What is the tax credit for R&D spending?
In 1981, concerned that spending for research activities was not adequate and was in fact declining, Congress enacted a nonrefundable income tax credit for incremental R&D expenses to overcome the reluctance of companies to bear the significant staffing and supply costs to conduct research programs in a trade or business.
The R&D tax credit is incremental in nature to encourage enlarged research efforts by companies that already may be engaged in some research activities. Section 41 was made a permanent provision of the Internal Revenue Code as part of the Protecting Americans from Tax Hikes Act of 2015 (PATH Act).
Coordinating the R&D tax credit with Section 174
Taxpayers may continue to use the §41 R&D credit alongside the §174A domestic R&E deduction and §174 foreign R&E amortization to reduce their tax burden. Section 280C(c) requires that any deduction under §174A be reduced by any R&D credit taken under §41, unless the taxpayer elects to reduce the R&D credit.
If a taxpayer capitalizes rather than deducts research expenditures, and the research credit for the year exceeds the amount allowable as a deduction for qualified or basic research expenses, then the amount chargeable to the capital account for such expenses must be reduced by the amount of the excess.
[Dig deeper into R&D tax rules with our comprehensive analysis of Sections 41, 174, and 174A.]
What qualifies for the R&D tax credit?
To qualify for the §41 R&D tax credit, a taxpayer must be engaged in “qualified research.” To be considered qualified research, R&D activities must meet a four-part test:
- Section 174A test
Research activity expenditures must be eligible for a §174A deduction. Section 174A deductions are allowed for expenditures incurred in connection with the taxpayer’s trade or business that represent research and development, conducted within the United States, in the experimental or laboratory sense.
- Technological information test
The taxpayer must conduct qualifying research for the purpose of discovering information that is technological in nature, with the intent of applying that information in the development of a new or improved business component. However, the taxpayer isn’t required to succeed in developing a new or improved business component from the discovered information for it to be qualifying research.
A taxpayer may use existing technologies and scientific principles to satisfy this requirement; it’s not necessary that the research be undertaken to expand or refine the common knowledge within a field of science.
- Process of experimentation test
Qualifying research activities must be part of a process of experimentation for a purpose relating to a new or improved function, performance, or reliability, with the intent that information to be discovered will be useful in the development of a new or improved business component. This experimentation process must be evaluative and generally should be capable of evaluating more than one alternative.
Research related to style, taste, cosmetic, or seasonal design factors is not qualified research.
- Business component test
The tests for determining whether research is qualified research must be applied separately to each business component. If the tests for determining whether research activity is qualified research aren’t met at the level of the entire product, a “shrinking back” rule applies to the tests at the most significant subset of elements of the product or item for sale, lease, or license. This rule continues until either:
- A subset of the product satisfies the tests, or
- The most basic element of the product is reached, and it fails to satisfy the tests
What are eligible R&D expenses?
The IRS defines qualified research expenses (QREs) “as the sum of in-house research expenses and contract research expenses.” In-house research expenses include the costs of:
- Employee wages for qualified services performed by such employee;
- Supplies used to conduct qualified research; and
- Computers used to conduct qualified research
What is the 80% rule for R&D credit?
The IRS notes that if “substantially all” – that is, at least 80% – of the services performed by an employee fit the criteria of qualified research, then all of the employee’s annual wages are eligible as QREs.
But employers must take care to identify workers whose wages are claimed as QREs. The IRS notes that when auditing the research credit, “payroll records, employee job descriptions, performance evaluations, calendars and appointment books are good sources of information.”
And counting up qualified hours worked is what matters most when preparing to take this credit. The agency cautions that “determinations as to whether an employee is (or is not) engaged in qualified services, should not be based solely on job descriptions or titles” and that “eligibility is based solely upon what an employee actually does, or does not, do during a specific time period.”
What does not qualify as R&D?
The IRS provides a brief description of activities for which the §41 R&D tax credit is not allowed. These include but are not limited to:
- Any research conducted after the beginning of commercial production of the business component
- Any research related to the adaptation of an existing business component
- Any research related to the reproduction of an existing business component (in whole or in part) from a physical examination of the business component itself or from plans, blueprints, detailed specifications, or publicly available information
- Efficiency surveys, routine data collection, or ordinary testing for quality control
- Research conducted outside the United States
- Research supported by any grant, contract, or otherwise by another person or governmental entity
Who is eligible for the §41 R&D tax credit?
Tax professionals should refer to §174A when determining who or what qualifies for R&D tax credit.
According to advisory firm Cherry Bekaert, research and development tax deductions had once been associated only with businesses working in fields such as biotechnology and pharmacology. However, the firm notes that U.S. Department of Treasury regulations have “substantially broadened the range of taxpayers” eligible for the R&D tax credit.
Case law suggests that a taxpayer may establish that research expenditures were made in connection with a trade or business by showing a nontax profit motive and active involvement demonstrated by substantial and regular involvement in the activity. A good faith intention to make a profit is required, but the expectation of profit need not be reasonable.
Courts have held that expenditures of startup enterprises are deductible where the taxpayer demonstrates a realistic prospect of entering a trade or business involving technology. To this end, an objective intent to enter a trade or business and the capability to do so must be shown.
Download Now: Research & Development Special Report for authoritative guidance on Sections 41, 174, and 174A.
Take advantage of the R&D tax credit with expert insights from Bloomberg Tax
2025 is shaping up to be a pivotal year for tax policy, with significant changes on the horizon that could complicate federal tax planning strategies. The tax treatment of R&D expenditures is an important part of corporate tax planning strategies that help companies to innovate and remain competitive in the marketplace.
To stay on top of it all, rely on the resources, innovations, and unmatched expertise that only Bloomberg Tax provides, including up-to-the-moment intelligence and expert analysis.
Request a demo to learn how Bloomberg Tax helps tax professionals in the technology industry plan today for the realities of tomorrow.